Wells Fargo’s Gossamer Bio GOSS Stock Holding History

Wells Fargo’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,198	Closed	-$1.2M	–	7436
2021 Q3	$1.2M	Buy	+1,198	New	+$882K	﹤0.01%	4084

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Wells Fargo's GOSS Position: Q2 2026 in Review

Wells Fargo reduced its Gossamer Bio (GOSS) stake by 92% in Q2 2026, selling an estimated $19.5K and leaving 81 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #6454.

Wells Fargo first reported a position in GOSS in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.12M in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Wells Fargo held 81 shares of Gossamer Bio worth $1.07K as of Q2 2026.
Wells Fargo sold 872 Gossamer Bio shares in Q2 2026, an estimated $19.5K.
Gossamer Bio made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6454 holding.
Wells Fargo first reported a position in Gossamer Bio in Q1 2019 and has held it in 28 quarters since.
Wells Fargo's Gossamer Bio position peaked at $1.12M in Q4 2025.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.